$35 Billion Windfall STUNS Medicare Watchdogs

Wooden block with MEDICARE text next to a stethoscope — MEDICARE BOMBSHELL

Health insurers scored a stunning $35 billion windfall from the Trump administration’s finalization of Medicare Advantage rates, raising urgent questions about fiscal discipline versus industry power.

Story Snapshot

CMS finalized a 7.2% payment increase for 2026, delivering $35 billion more to plans than 2025 levels.
Star ratings changes add $18.6 billion over a decade, surpassing initial estimates.
Amid record lobbying, insurers avoided feared cuts despite $76-84 billion annual overpayment concerns.
Beneficiaries gain short-term stability, but long-term sustainability risks persist for 35 million enrollees.
Contradictory signals: generous 2026 boost follows flat 2027 proposal.

Finalized Rates Exceed Expectations

CMS announced the 2026 Medicare Advantage payment rates on April 6, delivering a 7.2% increase over 2025. This outpaced the January Advance Notice’s 4.3% projection and prior years’ 3.7% and 3.3% rises.

The boost stems from 9.0% growth in traditional Medicare spending per person, offset by a -3.0% risk adjustment tweak and -1.0% other factors. A 2.1% upcoding contribution added $10 billion. Insurers like UnitedHealth and Humana breathed a sigh of relief after tense months.

The US Medicare program will pay private insurers 2.48% more in 2027, a meaningful improvement over the initial rates the agency proposed in January https://t.co/ynS7Ip3kK0

— Bloomberg (@business) April 6, 2026

Timeline of Uncertainty and Lobbying Pressure

January 2026 saw CMS project 4.3% growth, but January 26 brought a proposed less-than-0.1% 2027 increase, igniting backlash. April 2 revealed $18.6 billion in star ratings bonuses, topping the $13.2 billion forecast. April 6 sealed the 7.2% deal.

CMS noted unprecedented input on the 2027 proposal. Industry threats of benefit cuts for 35 million seniors amplified pressure. Power dynamics favored giants with deep lobbying pockets.

Overpayments Fuel Policy Tensions

MedPAC pegs Medicare Advantage overpayments at 20% per person versus traditional Medicare, totaling $84 billion in 2025. Upcoding drives $76 billion annually, with improper payments hitting 6.0% or $23.67 billion in FY 2025, up from prior year.

The administration finalized Biden-era risk models and education cost adjustments to curb this. Yet the 7.2% hike perpetuates excess. Common sense demands stronger fraud enforcement over endless subsidies.

Stakeholders clash sharply. Insurers and AHIP warned of premium hikes without boosts. MedPAC and groups like American Economic Liberties Project push restraint, calling flat 2027 rates a smart start. Congress eyes spending growth. Beneficiaries dodge short-term pain but risk future squeezes as funds divert from traditional Medicare.

Short-Term Wins Mask Long-Term Risks

Insurers pocket $35 billion extra in 2026 plus star bonuses, easing service cut fears and spurring potential improvements. Seniors maintain coverage stability now. Federal budgets swell by billions, clashing with conservative fiscal priorities.

Market tilts toward UnitedHealth and Humana, squeezing smaller players if 2027 stays flat. What happens when lobbying meets promised austerity?

Long-term, overpayments erode program viability without enforcement. Improper payments trend upward absent checks. 2027’s minimal proposal hints at course correction, but industry influence proved potent.

Traditional enrollees lose as Advantage siphons resources. True reform balances choice with taxpayer protection—industry threats ring hollow against documented waste.